Press "Enter" to skip to content

Zymeworks Reports Inducement Grant Under New York Stock Exchange Listed Company Manual Rule

Read, enjoy and share the latest news features on Canada Morning Post

Read, enjoy and share the latest news in Canada

VANCOUVER, British Columbia & SEATTLE — Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today reported, as required by the New York Stock Exchange Listed Company Manual Rule 303A.08 (the “NYSE Rule”), an equity inducement award to Mr. Kenneth Galbraith, Zymeworks’ new Chair, President and Chief Executive Officer. Read More

Other News:   Two invigilators suspended for using mobile phones in examination centres

Continue Reading News Story. Published by Central Press Syndicate – Toronto, Canada. For feedback write to Amnon Jakony, Founding Editor/Publisher – amnon [at] thedailyreformer.com. Thanks for reading.

Continue Reading News Story. Published by Canada Central Press Syndicate. For feedback write to Amnon Jakony, Founding Editor/Publisher - amnon [at] thedailyreformer.com. Thanks for reading.

Other News:   Chinese stabilizer manufacturer Hohem’s product lineup now available at Jarir Bookstore, enabling the shooting of better videos
Mission News Theme by Compete Themes.